Summary
In this article, a distinction is proposed between safe and less safe antidepressants. The safety of 18 antidepressants is discussed in relation to 3 principal issues: the safety of the drug in the event of an overdose; the seriousness of its side effects; and the existence of dangerous interactions. On the basis of present information, it can be said with reasonable confidence that fluoxetine, fluvoxamine and paroxetine are safe antidepressants, and with some reservation (mainly because of hypnosedation) the same can be said of mianserin and trazodone.
Similar content being viewed by others
References
Bancroft JHJ, Skrimshire AM, Sinkin S. The reasons people give for taking overdoses. British Journal of Psychiatry 128: 538–548, 1976
Benfield P, Ward A. Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32: 313–334, 1986
Bernard PG, Levin MS. Maprotiline induced seizures. Southern Medical Journal 79: 1179–1181, 1986
Branconnier RJ, Cole JO, Ghazvinian S, Rosenthal S. Treating the depressed elderly patient: the comparative behavioural pharmacology of mianserine and amitriptyline. Advances in Biochemical Psychopharmacology 32: 195–212, 1982
Burrows G, Norman T, Dennerstein L, et al. Antidepressant therapy: benefits and risks in perspective. Acta Psychiatrica Scandinavica 72: S435–S447, 1985
Claghorn JL, Schroeder J, Goldstein BJ. Comparison of the electrocardiographic effect of dothiepin and amitriptyline. Journal of Clinical Psychiatry 45: 291–293, 1984
Coccaro EF, Siever LJ. Second generation antidepressants: a comparative review. Journal of Clinical Pharmacology 25: 241–260, 1985
Comprehensive monograph Prozac. Dista Indianapolis, 1988
Dechant KL, Clissold SP. Paroxetine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 41: 225–253, 1991
Dukes MNG, Beeley L. Side effects of drugs. Elsevier Annual 12, Chapter 12, Amsterdam, 1988
Edwards JC, Glen-Bott M. Mianserine and convulsive seizures. British Journal of Clinical Pharmacology 15: 299s–311s, 1983
Edwards JG. Antidepressants and seizures: epidemiological and clinical aspects. In Trimble MR (Ed.) The psychopharmacology of epilepsy, pp. 119–139, Wiley, Chichester, 1985
Feighner JP. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. Journal of Clinical Psychiatry 46: 369–372, 1985
Gerner R, Estabrook W, Steuer J, et al. Treatment of geriatric depression with trazodone, imipramine and placebo: a double-blind study. Journal of Clinical Psychiatry 41: 216–220, 1980
Glassman AH, Bigger JT, Giardina EV, et al. Clinical characteristics of imipramine induced orthostatic hypotension. Lancet 1: 468–472, 1979
Glassman AH, Roose SP. Cardiovascular effects of tricyclic antidepressants. Psychiatry Ann 27: 340–344, 1987
Goodman-Gilman, et al. (Eds) The pharmacological basis of therapeutics, VIII Ed., p. 412, Pergamon Press, New York, 1990
Guze SB, Robins E. Suicide and primary affective disorders. British Journal of Psychiatry 117: 437–438, 1970
Harsch HH, Holt RE. Use of antidepressants in attempted suicide. Hospital and Community Psychiatry 39: 990–992, 1988
Hayes PE, Kristoff CA. Adverse reactions to five new antidepressants. Clinical Pharmacy 5: 472–480, 1986
Henry JA. A fatal toxicity index for antidepressant poisoning. Acta Psychiatrica Scandinavica 80: 37–45, 1989
Hindmarch I. A pharmacological profile of fluoxetine and other antidepressants on aspects of skilled performance and car handling ability. British Journal of Psychiatry 153 (Suppl. 3): 99–104, 1988
Hindmarch I. A double-blind, placebo-controlled investigation of the effects on psychomotor performance of paroxetine and amitriptyline with or without alcohol in adult subjects. Lecture at the 17th CINP Congress, Kyoto, September, 1990
Hindmarch I. Behavioural toxicity of antidepressants with particular reference to paroxetine. Lecture at the 5th World Congress of Biological Psychiatry, Florence, June 9–14, 1991
Hulten BA. TCA poisoning treated in the intensive care unit. Pharmacopsychiatry 23: 14–16, 1990
Inman WH. Blood disorders and suicide in patients taking mianserin or amitriptyline. Lancet 2: 90–92, 1988
Jabbari B, Bryan GE, Mars LEE, et al. Incidence of seizures with tricyclic and tetracyclic antidepressants. Archives of Neurology 42: 480–481, 1985
Kristofferson A, Nilsson BS. Zimelidine: febrile reactions and peripheral neuropathy. In Kammüller ME, Bloksma N, Seinen W (Eds) Autoimmunity and Toxicology, Elsevier, Amsterdam, 1989
Leonard BE. Toxicity of antidepressants. Lancet 2: 1105, 1986
Linkowski P, Maetelaerd V, Mendlewicz J. Suicidal behaviour in major depressive illness. Acta Psychiatrica Scandinavica 72: 233–238, 1985
Montgomery SA, Pinder RM. Do some antidepressants promote suicide? Psychopharmacology 92: 265–266, 1987
Pichot P, Dreyfus JF, Pull C. A double-blind multicentre trial comparing mianserin with imipramine. British Journal of Psychopharmacology 5: 87s–90s, 1978
Pinder RM. The benefits and risks of antidepressant drugs. Human Psychopharmacology 3: 73–86, 1988
Pinder RM, Blum A, Stulemeijer SM, et al. A double-blind multicenter trial comparing the efficacy and side-effects of mianserine and clomipramine in depressed inpatients and outpatients. Current Medical Research and Opinion 6 (Suppl. 7): 115–127, 1980
Prager G, Cimander K, Wagner W, et al. The cardiotropic effect of antidepressants. Advances in Pharmacotherapy 2: 133–150, 1986
Preskorn SH, Jerkovich GS. Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and the role of therapeutic drug monitoring. Journal of Clinical Psychopharmacology 10: 88–95, 1990
Richens A, Nawishi S, Trimble M. Antidepressant drugs, convulsions and epilepsy. British Journal of Clinical Pharmacology 15: 295s–298s, 1983
Robinson DS. Adverse reactions, toxicities, and drug interactions of newer antidepressants: anticholinergic, sedative and other side-effects. Psychopharmacology Bulletin 20: 280–290, 1984
Roos JC, Sharp DJ. Antidepressant drugs and cardiovascular effects. A comparison of fluvoxamine and the tricyclic antidepressant drugs. In Burrows et al. (Eds) Biological psychiatry: recent studies, John Libbey, London, 1984
Roose SP, Glassman AH, Giardina EGV, et al. Tricyclic antidepressants in depressed patients with cardiac conduction disease. Archives of General Psychiatry 44: 273–275, 1987
Shaw CA, Sullivan JT, Kadlec KE, Kaplan HL, Naranjo CA, et al. Ethanol interactions with serotonin uptake selective and non-selective antidepressants: fluoxetine and amitriptyline. Human Psychopharmacology 4: 113–120, 1989
Stallone F, Dunner DL, Ahean J, et al. Statistical prediction of suicide in depressives. Comprehensive Psychiatry 21: 381–387, 1982
Stark P, Hardison CD. A review of multicenter controlled studiers of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. Journal of Clinical Psychiatry 46: 53–58, 1985
Syssain EC, Schatzberg AF, Woods BT, et al. Maprotiline treatment in depression. Archives of General Psychiatry 43: 86–90, 1986
Teicher MH, Glod C, Cole JO. The emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry 147: 207–210, 1990
Tesar GE, Rosenbaum JF, Biederman J, et al. Orthostatic hypotension and antidepressant pharmacotherapy. Psychopharmacology Bulletin 23: 182–186, 1987
Warrington SJ, Padgham C, Lader M. The cardiovascular effects of antidepressants. In Psychological Medicine, monograph Suppl. 16, Cambridge University Press, 1989
Worm K, Steentoft A. Fatal poisoning by cyclic antidepressants. Pharmacopsychiatry 23: 9–13, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Jonghe, F., Swinkels, J.A. The Safety of Antidepressants. Drugs 43 (Suppl 2), 40–47 (1992). https://doi.org/10.2165/00003495-199200432-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199200432-00007